BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sinn DH, Lee HI, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Virological response to adefovir monotherapy and the risk of adefovir resistance. World J Gastroenterol 2011; 17(30): 3526-3530 [PMID: 21941420 DOI: 10.3748/wjg.v17.i30.3526]
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3526.htm
Number Citing Articles
1
Thuan Duc Lao, Hung Chi Lieu, Thuy Thanh Thi Ho, Thuy Ai Huyen Le. 7th International Conference on the Development of Biomedical Engineering in Vietnam (BME7)IFMBE Proceedings 2020; 69: 605 doi: 10.1007/978-981-13-5859-3_103
2
Dan-Hong Yang, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, Hai-Jun Huang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patientsWorld Journal of Gastroenterology 2015; 21(9): 2746-2753 doi: 10.3748/wjg.v21.i9.2746
3
Fen Liu, Xiwei Wang, Fang Wei, Huaidong Hu, Dazhi Zhang, Peng Hu, Hong Ren. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysisVirology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-59